BindingDB logo
myBDB logout

BDBM322113 1-{5-[1-(3-Chlorophenyl)ethoxy]-1-(cyclohexylmethyl)-1H-pyrazol-3-yl}-N-methylmethanamine hydrochloride::US10183913, Example 350

SMILES: CNCc1cc(OC(C)c2cccc(Cl)c2)n(CC2CCCCC2)n1

InChI Key: InChIKey=BCKNAJHBZGRSDP-UHFFFAOYSA-N

Data: 2 KI

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 322113   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
5-hydroxytryptamine receptor 2C


(Homo sapiens (Human))
BDBM322113
PNG
(1-{5-[1-(3-Chlorophenyl)ethoxy]-1-(cyclohexylmethy...)
Show SMILES CNCc1cc(OC(C)c2cccc(Cl)c2)n(CC2CCCCC2)n1
Show InChI InChI=1S/C20H28ClN3O/c1-15(17-9-6-10-18(21)11-17)25-20-12-19(13-22-2)23-24(20)14-16-7-4-3-5-8-16/h6,9-12,15-16,22H,3-5,7-8,13-14H2,1-2H3
Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
11n/an/an/an/an/an/an/an/a



SUMITOMO DAINIPPON PHARMA CO., LTD.

US Patent


Assay Description
A solution of 200 μL in total was prepared by mixing 50 μL of [3H] mesulergine (manufactured by GE Healthcare) diluted with 50 mmol/L Tris-...


US Patent US10183913 (2019)


BindingDB Entry DOI: 10.7270/Q2MW2K73
More data for this
Ligand-Target Pair
Sodium-dependent serotonin transporter


(Homo sapiens (Human))
BDBM322113
PNG
(1-{5-[1-(3-Chlorophenyl)ethoxy]-1-(cyclohexylmethy...)
Show SMILES CNCc1cc(OC(C)c2cccc(Cl)c2)n(CC2CCCCC2)n1
Show InChI InChI=1S/C20H28ClN3O/c1-15(17-9-6-10-18(21)11-17)25-20-12-19(13-22-2)23-24(20)14-16-7-4-3-5-8-16/h6,9-12,15-16,22H,3-5,7-8,13-14H2,1-2H3
PDB

KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
53n/an/an/an/an/an/an/an/a



SUMITOMO DAINIPPON PHARMA CO., LTD.

US Patent


Assay Description
The [3H] citalopram binding was measured according to the method disclosed in Owens M. J. et al., J. Pharm. Exp. Ther., 283, 1305-1322 (1997). In spe...


US Patent US10183913 (2019)


BindingDB Entry DOI: 10.7270/Q2MW2K73
More data for this
Ligand-Target Pair